This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Pandemic-Led Demand Aids B&G Foods (BGS), High Costs Persist
by Zacks Equity Research
B&G Foods (BGS) is seeing robust demand amid sustained at-home consumption trend as well as recovery in foodservice business. However, high costs are a concern.
Smucker (SJM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Smucker (SJM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Smucker (SJM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Smucker (SJM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
B&G Foods (BGS) Q2 Earnings Miss Estimates, Sales Down Y/Y
by Zacks Equity Research
B&G Foods (BGS) second-quarter fiscal 2021 results reflect lower earnings and sales on unfavorable year-over-year comparisons. Also, input cost inflation affected quarterly results.
Kraft Heinz (KHC) Q2 Earnings Beat Estimates, Sales Down Y/Y
by Zacks Equity Research
Kraft Heinz's (KHC) second-quarter 2021 sales and earnings decline year over year on softness across United States business.
Colgate (CL) Q2 Earnings Match Estimates, Sales Surpass
by Zacks Equity Research
Colgate's (CL) Q2 results benefit from strong top-line growth across most of its segments, innovation and digital investments. However, margins were dismal and are likely to remain drab in 2021.
Church & Dwight (CHD) Cuts View Despite Q2 Earnings & Sales Beat
by Zacks Equity Research
Church & Dwight's (CHD) second-quarter 2021 results benefit from strong product demand. Management lowers view due to supply-chain woes and cost inflation.
4 Reasons Why The J.M. Smucker (SJM) Stock Appears Promising
by Zacks Equity Research
The J.M. Smucker (SJM) is benefiting from its prudent pricing efforts, brand strength and solid digital sales. The company's shareholder-friendly moves are also worth noting.
Inter Parfums (IPAR) Raises 2021 View Again on Solid Q2 Sales
by Vrishali Bagree
Inter Parfums (IPAR) came up with robust sales numbers for the second quarter of 2021, reflecting brand strength. Also, management raises guidance for 2021.
B&G Foods (BGS) Poised on E-commerce Growth, Prudent Buyouts
by Zacks Equity Research
B&G Foods (BGS) is gaining on higher online sales. The company is actively pursuing strategic acquisitions to boost growth.
Zacks Industry Outlook Highlights: Mondelez International, J.M. Smucker, Lamb Weston and Darling Ingredients
by Zacks Equity Research
Zacks Industry Outlook Highlights: Mondelez International, J.M. Smucker, Lamb Weston and Darling Ingredients
4 Food Stocks Worth Relishing Despite Industry Challenges
by Vidya Nair
The Zacks Food-Miscellaneous industry is facing headwinds surrounding at-home demand moderation. Nevertheless, portfolio growth efforts have been aiding Mondelez (MDLZ), The J.M. Smucker (SJM), Lamb Weston (LW) and Darling Ingredients (DAR).
The J. M. Smucker (SJM) Cheers Investors With Dividend Hike
by Zacks Equity Research
The J.M. Smucker (SJM) is likely to cement its position in investors' good books with the latest dividend hike of 10%. Cost-saving efforts and improved Away From Home division bode well.
The J.M. Smucker (SJM) Up About 15% YTD: Will Momentum Stay?
by Zacks Equity Research
The J.M. Smucker Company (SJM) is poised to benefit from solid pricing and a revival in the Away From Home division, though high costs are concerning.
Pandemic-Led Demand Aids B&G Foods (BGS), Higher Costs Hurt
by Zacks Equity Research
B&G Foods' (BGS) retail business is benefiting from high pandemic-led at home consumption. However, rising expenses associated with COVID-19 as well as cost inflation are a concern.
Company News for Jun 4, 2021
by Zacks Equity Research
Companies In The News Are: CIEN, SJM, NTAP, PVH
The J.M. Smucker (SJM) Q4 Earnings Top Estimates, Sales Down
by Zacks Equity Research
The J.M. Smucker's (SJM) fourth-quarter fiscal 2021 results reflect lower sales and earnings thanks to weakness across most segments. Nevertheless, sustained demand for at-home food was an upside.
How to Boost Your Portfolio with Top Consumer Staples Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
The J.M. Smucker (SJM) Queued for Q4 Earnings: Things to Note
by Zacks Equity Research
The J.M. Smucker's (SJM) fourth-quarter fiscal 2021 results are likely to reflect soft sales and earnings due to the lapping of pandemic-related higher sales, divestiture impacts and marketing investments.
Earnings Preview: Smucker (SJM) Q4 Earnings Expected to Decline
by Zacks Equity Research
Smucker (SJM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lamb Weston (LW) Gains on Solid Retail Business, High Costs Hurt
by Zacks Equity Research
Lamb Weston (LW) is gaining on solid price/mix, efforts to expand capacity and a strong retail business. However, weakness in the foodservice channel and escalated costs are headwinds.
Factors Likely to Shape Grocery Outlet's (GO) Q1 Earnings
by Zacks Equity Research
Grocery Outlet's (GO) Q1 results are likely to reflect gains from focus on the digital platform and on-trend products. However, lower at-home consumption activities and COVID-related costs remain concerns.
Factors Likely to Impact Energizer Holdings' (ENR) Q2 Earnings
by Zacks Equity Research
Energizer Holdings' (ENR) second-quarter numbers are likely to reflect gains from higher demand conditions amid the pandemic.
B&G Foods (BGS) to Post Q1 Earnings: What Awaits the Stock?
by Zacks Equity Research
B&G Foods' (BGS) first-quarter numbers are likely to reflect gains from higher demand conditions amid the pandemic.
Here's How Medifast (MED) is Placed Ahead of Q1 Earnings
by Zacks Equity Research
Strength in the OPTAVIA lifestyle solution and coaching support system have most likely aided Medifast's (MED) first-quarter 2021 performance.